Cochrane and MAGIC partnership: results from musculoskeletal pilot project on arthroscopic surgery for degenerative knee disease

Article type
Authors
O'Connor D1, Johnston R2, Brignardello-Petersen R3, O Vandvik P4, Agoritsas T5, van de Velde S4, Phillips S6, Buchbinder R2
1Cochrane EPOC and Musculoskeletal, Monash University
2Cochrane Musculoskeletal, Monash University
3McMaster University & Universidad de Chile
4MAGIC & Norwegian Institute of Public Health
5McMaster University & University of Geneva
6Therapeutic Guidelines Limited
Abstract
Background: Cochrane Musculoskeletal and MAGIC are working on pilot projects to explore jointly innovations in sharing work and data to harmonise flow from musculoskeletal reviews to guidelines and decision support systems. Arthroscopic surgery for degenerative knee disease is a low-value treatment practice where large variation exists and research translation is urgently needed.

Objectives: To describe our experiences and progress with a Cochrane Musculoskeletal-MAGIC partnership pilot project on arthroscopic surgery for degenerative knee disease.

Methods: In 2017 Cochrane Musculoskeletal contributed to a BMJ Rapid Recommendation (and related BMJ Open Rapid Review) on knee arthroscopy for degenerative knee disease. A strong recommendation against the use of arthroscopy in nearly all patients with degenerative knee disease was made. Cochrane Musculoskeletal recently converted the rapid review to a Cochrane Review incorporating new evidence. MAGICapp and SHARE-IT were used to create a decision aid (de-implementation tool) to disseminate this evidence to people with knee osteoarthritis considering arthroscopic surgery. The content of the decision aid was informed by qualitative interviews with consumers and health professionals about their information needs and preferences for a knee arthroscopy decision aid. The decision aid is being piloted with Australian consumers and clinicians. Methods to integrate it with Australian primary care electronic health record (EHR) management software are being explored. The decision aid for knee arthroscopy will be evaluated in a randomised trial in Australian primary care. Therapeutic Guidelines will update their guideline recommendation if needed.

Results: We will present the results within the Evidence Ecosystem (Figure 1), including: barriers and facilitators for evidence synthesis, development of the decision aid in MAGICapp, and plans for implementation and evaluation.

Conclusions: The Evidence Ecosystem for musculoskeletal conditions, as illustrated by this case study in knee arthroscopy for degenerative knee disease, provides opportunities for closing the loop between synthesised evidence and improved care.

Patient or healthcare consumer involvement: The information needs and preferences of consumers were used to inform the content of the decision aid.